News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Seth Kiernan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/01/2023 |
4
| Seth Kiernan (VP, Chief Commercial Officer) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 11,813 shares
@ $2.17, valued at
$25.6k
Exercised 14,833 restricted stock units
@ $0
Exercised 5,286 restricted stock units
@ $0
Exercised 22,963 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Seth Kiernan (VP, Chief Commercial Officer) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 206,670 options to buy
@ $3.2, valued at
$661.3k
Granted 68,890 restricted stock units
@ $0 |
|
| 10/29/2021 |
3
| Seth Kiernan (VP, Chief Commercial Officer) has filed a Form 3 on LEXICON PHARMACEUTICALS, INC. |
|
|